| Structural neuroimaging in aging and Alzheimer's disease. | |
| | |
MedLine Citation:
|
PMID: 22284732 Owner: NLM Status: In-Data-Review |
Abstract/OtherAbstract:
|
The role of structural neuroimaging in the diagnosis of Alzheimer's disease (AD) is becoming increasingly important. As a consequence, a basic understanding of what are normal brain changes in aging is key to be able to recognize what is abnormal. The first part of this article discusses normal versus pathologic brain aging, focusing on qualitative and quantitative magnetic resonance (MR) imaging markers. In the second part, the role of MR imaging in the (differential) diagnosis of AD is reviewed. |
| | |
Authors:
|
Meike W Vernooij; Marion Smits |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Neuroimaging clinics of North America Volume: 22 ISSN: 1557-9867 ISO Abbreviation: Neuroimaging Clin. N. Am. Publication Date: 2012 Feb |
Date Detail:
|
Created Date: 2012-01-30 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9211377 Medline TA: Neuroimaging Clin N Am Country: United States |
Other Details:
|
Languages: eng Pagination: 33-55 Citation Subset: IM |
Copyright Information:
|
Copyright © 2012 Elsevier Inc. All rights reserved. |
Affiliation:
|
Department of Radiology, Erasmus MC University Medical Center, PO Box 2040, 3000 CA Rotterdam, The Netherlands; Department of Epidemiology, Erasmus MC University Medical Center, PO Box 2040, 3000 CA Rotterdam, The Netherlands. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Clinical and Research Diagnostic Criteria for Alzheimer's Disease.
Next Document: Molecular neuroimaging in Alzheimer's disease.